A retrospective bicenter comparative study of surgical outcomes of atypical femoral fracture: Potential effect of teriparatide on fracture healing and callus formation
- PMID: 31398503
- DOI: 10.1016/j.bone.2019.08.006
A retrospective bicenter comparative study of surgical outcomes of atypical femoral fracture: Potential effect of teriparatide on fracture healing and callus formation
Abstract
Background: The main purpose of the present study was to assess the radiologic effect of teriparatide on fracture healing, including union rate, union time, and callus formation, by quantitative measurements using serial follow-up X-ray imaging examinations in patients with complete atypical femoral fractures (AFFs) treated using closed intramedullary nailing.
Methods: From January 2010 to October 2017, 58 consecutive patients with complete AFF who were treated with intramedullary nailing at two institutions were enrolled. Patients were classified into two groups: those who received teriparatide therapy (group A) and those who did not (group B). Teriparatide (Forsteo®; Eli Lily Co., Indianapolis, IN, USA) at a once-daily 20 μg dose was prescribed as continuous treatment of osteoporosis or with the expectation of better bone healing. Surgical outcomes, including union rate, union time, modified radiologic union score (mRUS), and callus formation at 3, 6, and 12 months postoperatively, were assessed to evaluate the effect of teriparatide on fracture healing. Quantitative measurement of callus formation was performed using the region of interest (ROI) tool in the picture archiving communication system (PACS).
Results: Non-union was not observed in group A, whereas two patients had non-union in group B. Union time was 18.3 ± 4.8 (range, 12-28) weeks in group A and 23.6 ± 9.5 (range, 12-64) weeks in group B and was significantly shorter in group A than group B (p = 0.010). The average mRUSs during periods A (3-4 months postoperatively), B (6-8 months postoperatively), and C (12-14 months postoperatively) were 10.0, 13.9, and 15.9 in group A, and 8.7, 12.0, and 14.9 in group B, respectively. The average mRUSs during periods A and B were significantly different (p = 0.027 and 0.011, respectively). The medial, posterior, and total callus areas during periods A and B were also significantly greater in group A than in group B. No difference was observed in the union rate between the two groups (p = 0.492).
Conclusion: Teriparatide may improve callus formation and shorten union time in patients with complete diaphyseal AFF who underwent closed intramedullary nailing.
Level of evidence: Level III retrospective comparative study.
Keywords: Atypical femoral fracture; Callus formation; Fracture healing; Teriparatide.
Copyright © 2019 Elsevier Inc. All rights reserved.
Similar articles
-
The effects of teriparatide on acceleration of bone healing following atypical femoral fracture: comparison between daily and weekly administration.Osteoporos Int. 2018 Dec;29(12):2659-2665. doi: 10.1007/s00198-018-4658-7. Epub 2018 Aug 13. Osteoporos Int. 2018. PMID: 30105400
-
Combination therapy with low-dose teriparatide and zoledronate contributes to fracture healing on rat femoral fracture model.J Orthop Surg Res. 2018 Oct 25;13(1):267. doi: 10.1186/s13018-018-0917-8. J Orthop Surg Res. 2018. PMID: 30359257 Free PMC article.
-
Healing of bisphosphonate-associated atypical femoral fractures in patients with osteoporosis: a comparison between treatment with and without teriparatide.J Bone Miner Metab. 2015 Sep;33(5):553-9. doi: 10.1007/s00774-014-0617-3. Epub 2014 Sep 17. J Bone Miner Metab. 2015. PMID: 25227287
-
Medical Management of Patients After Atypical Femur Fractures: a Systematic Review and Recommendations From the European Calcified Tissue Society.J Clin Endocrinol Metab. 2020 May 1;105(5):1682-99. doi: 10.1210/clinem/dgz295. J Clin Endocrinol Metab. 2020. PMID: 31867670 Free PMC article.
-
Use of teriparatide in osteoporotic fracture patients.Injury. 2016 Jan;47 Suppl 1:S36-8. doi: 10.1016/S0020-1383(16)30009-2. Injury. 2016. PMID: 26768289 Review.
Cited by
-
Global current research status and future hotspots in osteoporotic fracture based on bibliometric assessment and visualization techniques.World J Clin Cases. 2024 Jul 6;12(19):3908-3917. doi: 10.12998/wjcc.v12.i19.3908. World J Clin Cases. 2024. PMID: 38994286 Free PMC article.
-
Fracture Risk Following an Atypical Femoral Fracture.J Bone Miner Res. 2022 Jan;37(1):87-94. doi: 10.1002/jbmr.4461. Epub 2021 Nov 9. J Bone Miner Res. 2022. PMID: 34668223 Free PMC article.
-
Effects of Teriparatide on Treatment Outcomes in Osteoporotic Hip and Pelvic Bone Fractures: Meta-analysis and Systematic Review of Randomized Controlled Trials.Hip Pelvis. 2020 Dec;32(4):182-191. doi: 10.5371/hp.2020.32.4.182. Epub 2020 Dec 3. Hip Pelvis. 2020. PMID: 33335866 Free PMC article. Review.
-
The effect of osteoporosis and its treatment on fracture healing a systematic review of animal and clinical studies.Bone Rep. 2021 Aug 16;15:101117. doi: 10.1016/j.bonr.2021.101117. eCollection 2021 Dec. Bone Rep. 2021. PMID: 34458509 Free PMC article. Review.
-
The Effect of Teriparatide on the Hip: A Literature Review.Hip Pelvis. 2021 Jun;33(2):45-52. doi: 10.5371/hp.2021.33.2.45. Epub 2021 Jun 4. Hip Pelvis. 2021. PMID: 34141690 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials